Search Results

About two months into CEO Belén Garijo’s new tenure, Sanofi’s R&D chief has departed, with Xaira’s chief medical officer set to take charge of the pharma’s pipeline.

Dipharma Francis S.r.l. proudly announced that Dipharma Inc., its US facility located in Kalamazoo, MI, has been inspected by the U.S. Food and Drug Administration and has received the Establishment Inspection Report, satisfactorily closing the inspection process.

L7 Informatics’ position is that generative AI has been deployed in regulated science with only half the architecture it needs, and that the missing half is an active knowledge graph generated at the point of execution.

PD-(L)1×VEGF bispecifics have emerged as a closely watched new class in immuno-oncology, with multiple candidates advancing through trials in lung cancer. But the potential of these drugs may be highest in cancers where angiogenesis and immune escape are tightly intertwined.

Dipharma Francis S.r.l. announced the completion of the expansion of its Research and Development Center for small molecules at its Headquarters located in Baranzate, close to Milan, in the North of Italy.

Dipharma Francis S.r.l., a leading Contract Development and Manufacturing Organization and a global manufacturer of Active Pharmaceutical Ingredients, announced another new production site of the Group, thefacility located in Caronno Pertusella, near Milan, has received the Good Manufacturing Practice certification - CBPF - from the Regulatory Authority of Brazil, ANVISA.

Dipharma Francis S.r.l. announced the completion of the second phase of expansion of its American site, Dipharma Inc., located in Kalamazoo, MI.